
Recent posters at SID revealed significant increases in psoriasis and cellulitis cases in the US, highlighting urgent needs for prevention and treatment strategies.

Recent posters at SID revealed significant increases in psoriasis and cellulitis cases in the US, highlighting urgent needs for prevention and treatment strategies.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

The new partnership brings RNA-targeted innovation to dermatology-relevant disease areas like autoimmunity and cancer.

Hershel Dobkin, MD, FAAD, discusses the surprising truth about toughness in dermatology, unexpected patient reactions, and the emotional depth behind appearances.

This review of the latest dermatologic studies includes insights into switching PD-1 to BRAF + MEK inhibition, clinical outcomes and prognosis in atypical fibroxanthoma, and more.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

New research reveals a promising strategy to slow type 1 diabetes progression by targeting inflammation with an existing psoriasis drug.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Seven dermatologists have received GLODERM x CeraVe Access Grants to expand skin care access in underserved communities worldwide.

Discover an innovative non-surgical keloid treatment protocol that achieves high satisfaction and low recurrence rates for patients with darker skin tones.

In a new study, AI-driven personalized treatments significantly enhanced hair growth and scalp health, offering innovative solutions for hair loss management.

Explore the top headlines of the week including insights on the latest clinical trials, therapeutic updates, and more.

Test your knowledge of key words and terms associated with dermatology news from the previous week.

In case you missed it, this week we had news about roflumilast’s dual-site efficacy in psoriasis patients, melanoma care in the United States, phase 2a safety and efficacy results of AX-158, and more.

This week, we feature top articles from our sister publications on regulatory updates, clinical trial insights, and more.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Desai reflects on his AAD presidency, addressing Medicare challenges, technological advancements, and the future of dermatology leadership.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

FDA accelerates AI integration by 2025, enhancing scientific reviews and modernizing regulatory processes for improved public health outcomes.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

This review of the latest dermatologic studies includes insights into short- and long-term effects of topical cosmetics to dermatological procedures, adverse effects of omalizumab in urticaria, and more.

Explore innovative strategies for managing alopecia areata with insights from expert Susan Taylor, MD, FAAD, highlighting breakthrough JAK inhibitors and real-world case studies.

Explore the hidden health risks of nail products and the urgent need for safety reforms in the nail salon industry for workers and customers alike.

Catch up on dermatology news, highlights, and insights from the past 24 hours.